Atox Bio is a late stage, critical care immunotherapy company focusing on acute, life threatening, conditions with significant unmet need. We are developing Reltecimod, an immunomodulator, which is designed to enhance resolution of organ failure in conditions associated with severe, acute inflammation such as Necrotizing Soft Tissue Infection (NSTI) and sepsis.
Company Details
- Employees
- 7
- Address
- Durham, North Carolina
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.atoxbio.org/
- Keywords
- Jerusalem.
- HQ
- Durham, North Carolina
Atox Bio Questions
Atox Bio's website is https://www.atoxbio.org/
Atox Bio's LinkedIn profile is https://www.linkedin.com/company/ato-x-bio
Atox Bio has
7 employees.
View email and phone details for 7
employees at Atox Bio.
Atox Bio's industry is
Biotechnology Research
Atox Bio's top competitors are
Advanced Lipids,
Kol Biotec,
Accutox Llc,
Biohouse Group,
Hylabs (Hy Laboratories Ltd),
Service Center Pro,
Argaman Technologies Ltd.,
Ella Therapeutics,
Geneharmonics Inc..
Atox Bio's categories are Biotechnology Research
